Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

Drug interactions may be important risk factors for methotrexate neurotoxicity, particularly in pediatric leukemia patients.

Forster VJ, van Delft FW, Baird SF, Mair S, Skinner R, Halsey C.

Cancer Chemother Pharmacol. 2016 Nov;78(5):1093-1096. Epub 2016 Sep 22.

2.

Severe neurotoxicity following intrathecal methotrexate with nitrous oxide sedation in a child with acute lymphoblastic leukemia.

Löbel U, Trah J, Escherich G.

Pediatr Blood Cancer. 2015 Mar;62(3):539-41. doi: 10.1002/pbc.25270. Epub 2014 Oct 31.

PMID:
25360802
3.

Effect of methotrexate/vitamin B12 on DNA methylation as a potential factor in leukemia treatment-related neurotoxicity.

Forster VJ, McDonnell A, Theobald R, McKay JA.

Epigenomics. 2017 Sep;9(9):1205-1218. doi: 10.2217/epi-2016-0165. Epub 2017 Aug 15.

4.

Methotrexate-related neurotoxicity in the treatment of childhood acute lymphoblastic leukemia.

Shuper A, Stark B, Kornreich L, Cohen IJ, Avrahami G, Yaniv I.

Isr Med Assoc J. 2002 Nov;4(11):1050-3. Review.

5.

Methotrexate-induced neurotoxicity and leukoencephalopathy in childhood acute lymphoblastic leukemia.

Bhojwani D, Sabin ND, Pei D, Yang JJ, Khan RB, Panetta JC, Krull KR, Inaba H, Rubnitz JE, Metzger ML, Howard SC, Ribeiro RC, Cheng C, Reddick WE, Jeha S, Sandlund JT, Evans WE, Pui CH, Relling MV.

J Clin Oncol. 2014 Mar 20;32(9):949-59. doi: 10.1200/JCO.2013.53.0808. Epub 2014 Feb 18.

6.

Methotrexate-induced subacute neurotoxicity in a child with acute lymphoblastic leukemia carrying genetic polymorphisms related to folate homeostasis.

Vagace JM, Caceres-Marzal C, Jimenez M, Casado MS, de Murillo SG, Gervasini G.

Am J Hematol. 2011 Jan;86(1):98-101. doi: 10.1002/ajh.21897.

7.

Acute methotrexate neurotoxicity revealed by a cerebellar syndrome.

Zahra K, Bouneb R, Mahjoub M, Zaghouani H, Zaier M, Ben Youssef Y, Khelif A.

Rev Neurol (Paris). 2016 Dec;172(12):791-793. doi: 10.1016/j.neurol.2016.09.005. Epub 2016 Oct 20. No abstract available.

PMID:
27773447
8.

[Neurotoxicity during induction treatment of childhood acute lymphoblastic leukaemia--two case reports].

Kostić G, Jovancić D, Saranac L, Bjelaković B.

Srp Arh Celok Lek. 2009 May-Jun;137(5-6):266-70. Serbian.

9.

Methotrexate-Induced Neurotoxicity in Hispanic Adolescents with High-Risk Acute Leukemia-A Case Series.

Giordano L, Akinyede O, Bhatt N, Dighe D, Iqbal A.

J Adolesc Young Adult Oncol. 2017 Sep;6(3):494-498. doi: 10.1089/jayao.2016.0094. Epub 2017 Mar 24.

PMID:
28338384
10.

[Nitrous oxide can cause cobalamin deficiency. Vitamin B12 is a simple and cheap remedy].

Lindstedt G.

Lakartidningen. 1999 Nov 3;96(44):4801-5. Review. Swedish.

PMID:
10584542
11.

Nitrous oxide "whippit" abuse presenting with cobalamin responsive psychosis.

Sethi NK, Mullin P, Torgovnick J, Capasso G.

J Med Toxicol. 2006 Jun;2(2):71-4. Review.

12.

A rare complication of intrathecal methotrexate in a child with acute lymphoblastic leukemia.

Tufekci O, Yilmaz S, Karapinar TH, Gozmen S, Cakmakci H, Hiz S, Irken G, Oren H.

Pediatr Hematol Oncol. 2011 Sep;28(6):517-22. doi: 10.3109/08880018.2011.563773. Epub 2011 Jun 24.

PMID:
21699468
13.

[Neurotoxicity due to methotrexate in paediatric patients. Description of the clinical symptoms and neuroimaging findings].

Garcia-Puig M, Fons-Estupina MC, Rives-Sola S, Berrueco-Moreno R, Cruz-Martinez O, Campistol J.

Rev Neurol. 2012 Jun 16;54(12):712-8. Spanish.

14.

[Effects of different first dose calcium tetrahydro-folate on toxicity and side effects of large dose methotrexate treated standard risk group children with acute lymphoblastic leukemia].

Fang CQ, Xu WQ, Tang YM, Song H, Shi S, Yang S.

Zhonghua Er Ke Za Zhi. 2004 May;42(5):392-3. Chinese. No abstract available.

PMID:
15189706
15.

Rechallenging With Intrathecal Methotrexate After Developing Subacute Neurotoxicity in Children With Hematologic Malignancies.

Badke C, Fleming A, Iqbal A, Khilji O, Parhas S, Weinstein J, Morgan E, Hijiya N.

Pediatr Blood Cancer. 2016 Apr;63(4):723-6. doi: 10.1002/pbc.25850. Epub 2015 Dec 18.

PMID:
26681571
16.

Neurologic degeneration associated with nitrous oxide anesthesia in patients with vitamin B12 deficiency.

Flippo TS, Holder WD Jr.

Arch Surg. 1993 Dec;128(12):1391-5. Review.

PMID:
8250714
17.

Clinical and radiological characteristics of methotrexate-induced acute encephalopathy in pediatric patients with cancer.

Inaba H, Khan RB, Laningham FH, Crews KR, Pui CH, Daw NC.

Ann Oncol. 2008 Jan;19(1):178-84. Epub 2007 Oct 17.

PMID:
17947226
18.

Dorsal column myelopathy after intrathecal chemotherapy for leukemia.

Pinnix CC, Chi L, Jabbour EJ, Milgrom SA, Smith GL, Daver N, Garg N, Cykowski MD, Fuller G, Cachia D, Kamiya-Matsuoka C, Woodman K, Dinardo C, Jain N, Kadia TM, Pemmaraju N, Ohanian M, Konopleva M, Kantarjian HM, Dabaja BS.

Am J Hematol. 2017 Feb;92(2):155-160. doi: 10.1002/ajh.24611.

19.

A woman who couldn't speak: report of methotrexate neurotoxicity.

Szawarski P, Chapman CS.

Postgrad Med J. 2005 Mar;81(953):194-5.

20.

Enhanced therapeutic effect of methotrexate in experimental rat leukemia after inactivation of cobalamin (vitamin B12) by nitrous oxide.

Kroes AC, Lindemans J, Schoester M, Abels J.

Cancer Chemother Pharmacol. 1986;17(2):114-20.

PMID:
3719892

Supplemental Content

Support Center